1.The association between cardiac function status and prognosis in patients with diabetic foot ulcers
Qiong HONG ; Min LI ; Jie YANG ; Jianyuan SHI ; Junyi GU ; Huili CAI ; Jianmin LIU ; Zhengyi TANG
Chinese Journal of Endocrinology and Metabolism 2025;41(7):540-545
Objective:To investigate the relationship between different states of cardiac function and their changes during the course of diabetic foot ulcers(DFU), and to evaluate their impact on patient prognosis.Methods:A retrospective analysis was conducted on 194 DFU patients who were rehospitalized at approximately 3-month intervals. Basic clinical data and cardiac function-related indicators were collected at baseline and follow-up. Patients were followed until death or until November 10, 2024. Outcomes including ulcer healing, recurrence, minor amputation, and death were recorded. Logistic regression models were used to analyze the effects of cardiac function status and its changes on these four outcomes. Results:After treatment, the proportion of patients with NYHA class Ⅱ-Ⅲ decreased significantly from 33.5% at baseline to 21.6%( P=0.009). Serum N-terminal pro-B-type natriuretic peptide(NT-proBNP) level also decreased after treatment compared with baseline [635.85(59.83, 453.28) pg/mL vs 728.67(81.48, 696.15) pg/mL, P=0.055]. Serum NT-proBNP level was significantly higher in the death group compared to the survival group( P=0.002). The proportion of DFU patients with baseline NYHA class Ⅱ-Ⅲ was significantly higher than that in those with class Ⅰ( P=0.012). Regression analysis showed that an improvement in NT-proBNP levels was associated with a lower risk of DFU recurrence( OR=0.378, 95% CI 0.183-0.779, P=0.008), and improvement in NYHA class was associated with a lower mortality risk( OR=0.074, 95% CI 0.020-0.275, P<0.001). Conclusion:Cardiac function status and its changes during the treatment of DFU patients have strong prognostic implications, particularly in predicting the risk of recurrence and death outcomes.
2.Experiences of food avoidance behavior in patients with inflammatory bowel disease:a qualitative study
Qingyu WANG ; Meijing ZHOU ; Yang LEI ; Sha LI ; Junyi GU ; Zheng LIN ; Qiugui BIAN ; Jiefeng YANG ; Lichen TANG ; Jiali CHEN ; Hantian CHENG
Chinese Journal of Nursing 2025;60(11):1323-1329
Objective This study applies Roy adaptation theory to deeply explore the experience of food avoid-ance behavior in patients with inflammatory bowel disease(IBD),offering insights for developing dietary management strategies.Methods A descriptive qualitative research method was employed.By purposive sampling,24 IBD pa-tients hospitalized in the gastroenterology department of a tertiary hospital in Nanjing from July 2022 to December 2024 were selected for semi-structured interviews.Data were analyzed using a directed content analysis approach.Results This study identified 4 main themes and 11 sub-themes,encompassing overattribution leading to inappro-priate avoidance(recurrent symptoms triggering overattribution,disease staging triggering inappropriate avoidance),negative self-perception leading management struggles(illness fear diminishing self-efficacy,disease trauma eroding self-identity,knowledge deficiency constraining self-determination),functional impairment intensifying role challenges(role internalization undermining social function,social roles relinquishing dietary management),and external con-straints amplifying practical difficulties(family and friend oversight heightening dietary stress,healthcare gaps foster-ing practical helplessness,traditional beliefs restricting dietary exploration,economic hardship limiting balanced nu-trition).Conclusion The interplay of overattribution,negative self-perception,functional impairment,and external constraints in IBD patients hinders their ability to adapt to disease fluctuations,ensnaring them in the adaptive predicament of food avoidance behavior.Healthcare professionals should comprehensively address these factors by fostering accurate perceptions,enhancing psychological support,guiding effective coping strategies,and optimizing ex-ternal resources,thereby improving patients' overall adaptive capacity and promoting their recovery.
3.Experiences of food avoidance behavior in patients with inflammatory bowel disease:a qualitative study
Qingyu WANG ; Meijing ZHOU ; Yang LEI ; Sha LI ; Junyi GU ; Zheng LIN ; Qiugui BIAN ; Jiefeng YANG ; Lichen TANG ; Jiali CHEN ; Hantian CHENG
Chinese Journal of Nursing 2025;60(11):1323-1329
Objective This study applies Roy adaptation theory to deeply explore the experience of food avoid-ance behavior in patients with inflammatory bowel disease(IBD),offering insights for developing dietary management strategies.Methods A descriptive qualitative research method was employed.By purposive sampling,24 IBD pa-tients hospitalized in the gastroenterology department of a tertiary hospital in Nanjing from July 2022 to December 2024 were selected for semi-structured interviews.Data were analyzed using a directed content analysis approach.Results This study identified 4 main themes and 11 sub-themes,encompassing overattribution leading to inappro-priate avoidance(recurrent symptoms triggering overattribution,disease staging triggering inappropriate avoidance),negative self-perception leading management struggles(illness fear diminishing self-efficacy,disease trauma eroding self-identity,knowledge deficiency constraining self-determination),functional impairment intensifying role challenges(role internalization undermining social function,social roles relinquishing dietary management),and external con-straints amplifying practical difficulties(family and friend oversight heightening dietary stress,healthcare gaps foster-ing practical helplessness,traditional beliefs restricting dietary exploration,economic hardship limiting balanced nu-trition).Conclusion The interplay of overattribution,negative self-perception,functional impairment,and external constraints in IBD patients hinders their ability to adapt to disease fluctuations,ensnaring them in the adaptive predicament of food avoidance behavior.Healthcare professionals should comprehensively address these factors by fostering accurate perceptions,enhancing psychological support,guiding effective coping strategies,and optimizing ex-ternal resources,thereby improving patients' overall adaptive capacity and promoting their recovery.
4.The association between cardiac function status and prognosis in patients with diabetic foot ulcers
Qiong HONG ; Min LI ; Jie YANG ; Jianyuan SHI ; Junyi GU ; Huili CAI ; Jianmin LIU ; Zhengyi TANG
Chinese Journal of Endocrinology and Metabolism 2025;41(7):540-545
Objective:To investigate the relationship between different states of cardiac function and their changes during the course of diabetic foot ulcers(DFU), and to evaluate their impact on patient prognosis.Methods:A retrospective analysis was conducted on 194 DFU patients who were rehospitalized at approximately 3-month intervals. Basic clinical data and cardiac function-related indicators were collected at baseline and follow-up. Patients were followed until death or until November 10, 2024. Outcomes including ulcer healing, recurrence, minor amputation, and death were recorded. Logistic regression models were used to analyze the effects of cardiac function status and its changes on these four outcomes. Results:After treatment, the proportion of patients with NYHA class Ⅱ-Ⅲ decreased significantly from 33.5% at baseline to 21.6%( P=0.009). Serum N-terminal pro-B-type natriuretic peptide(NT-proBNP) level also decreased after treatment compared with baseline [635.85(59.83, 453.28) pg/mL vs 728.67(81.48, 696.15) pg/mL, P=0.055]. Serum NT-proBNP level was significantly higher in the death group compared to the survival group( P=0.002). The proportion of DFU patients with baseline NYHA class Ⅱ-Ⅲ was significantly higher than that in those with class Ⅰ( P=0.012). Regression analysis showed that an improvement in NT-proBNP levels was associated with a lower risk of DFU recurrence( OR=0.378, 95% CI 0.183-0.779, P=0.008), and improvement in NYHA class was associated with a lower mortality risk( OR=0.074, 95% CI 0.020-0.275, P<0.001). Conclusion:Cardiac function status and its changes during the treatment of DFU patients have strong prognostic implications, particularly in predicting the risk of recurrence and death outcomes.
5.Influencing factors and nursing enlightenment of the fear of progression in patients with inflammatory bowel disease:a latent profile analysis
Qingyu WANG ; Zheng LIN ; Yang LEI ; Meijing ZHOU ; Mi WANG ; Caiyun SUN ; Junyi GU ; Zhanhui ZHU ; Lichen TANG ; Qiugui BIAN
Chinese Journal of Nursing 2024;59(3):308-316
Objective To explore the potential categories and influencing factors of the fear of progression in patients with inflammatory bowel diseases(IBD).Methods IBD patients who received inpatient treatment in a tertiary hospital in Nanjing from July 2022 to July 2023 were selected as the study subjects by convenience sampling method.The General Demographic Information Questionnaire,the Chinese version of the Fear of Progression Questionnaire-Short Form(FoP-Q-SF),the Chinese version of Inflammatory Bowel Disease Self-efficacy Scale(IBD-SES),and Social Support Rating Scale(SSRS)were administered to the participants.We applied one-way ANOVA and Logistic regression analysis to identify the factors associated with the potential categories of the fear of progression.Results A total of 303 retumed questionnaires(out of the 310)were valid,resulting an effective response rate of 97.74%.According to the results of latent profile analysis,we classified the respondents into 3 categories by the fear of progression,namely"low risk fear of disease adaptation group"(n=127,41.91%),"medium risk fear of illness distress group"(n=139,45.88%),"high risk fear of dysfunction group"(n=37,12.21%).3 groups showed statistically significant differences in permanent address,self-rated financial pressure,current disease status and self-efficacy(P<0.05).Conclusion Patients with IBD had obvious differences in characteristics on the fear of progression.Nursing personnel should formulate personalized intervention strategies based on the classification characteristics of the fear of progression of IBD patients.Moreover,nurses should focus on improving patients'self-efficacy and promoting patients to treat medical care,stress and emotion management correctly.
6.Status of research on diagnostic and treatment strategies for enamel hypoplasia
Quan TANG ; Junyi YANG ; Lei CHENG
Journal of Prevention and Treatment for Stomatological Diseases 2024;32(8):640-645
Enamel hypoplasia is a disease that results in enamel formation and mineralization abnormalities due to the effects of hereditary or environmental variables during tooth development.Affected teeth may appear to have an ab-errant color and structural flaws.Patients often display clinical signs such as tooth defects,tooth sensitivity,and tooth discoloration.The disease can cause patients to feel physically and mentally uncomfortable and negatively impact their ability to chew,swallow,speak,and smile.In this review,the pathophysiology of enamel hypoplasia,which is caused by anomalies in gene regulation and changes in environmental variables,is summarized,along with a list of clinical diag-nostic indicators based on the most commonly used disease classifications.The main points are as follows:① enamel hypoplasia changes only the color and transparency of the affected teeth;② lesions often occur symmetrically in groups;③ the age at which systemic diseases or nutritional disorders occur during tooth development can be predicted based on the patient's impaired teeth;and ④ banded or pitted brown depression on the enamel surface can easily be confused with dental fluorosis.It also elaborates on the comprehensive application of tooth bleaching,desensitization,direct or in-direct restoration and other treatment modalities according to unique chief complaints by different patients and suggests the use of multidisciplinary cooperative sequential treatment for critical infants and young children.The goal of this re-view is to provide professionals with the most recent information and advice about enamel hypoplasis.Current literature on this condition is primarily case reports.To further standardize the diagnostic and management approaches for this dis-ease,additional high-quality clinical research and systematic reviews are required.
7.Sinicization of Illness Identity Questionnaire and its reliability and validity in patients with inflammatory bowel disease
Lichen TANG ; Zheng LIN ; Yang LEI ; Sha LI ; Jiefeng YANG ; Junyi GU ; Zhanhui ZHU ; Qingyu WANG
Chinese Journal of Modern Nursing 2024;30(17):2302-2308
Objective:To translate the Illness Identity Questionnaire (IIQ) into Chinese and test its reliability and validity.Methods:The English version of IIQ was translated into Chinese and back-translated according to the Brislin model. The item of the Chinese version was determined after cross-cultural adaptation and pre-experiment. A total of 368 patients with IBD treated in the First Affiliated Hospital with Nanjing Medical University from September 2022 to March 2023 were selected for a questionnaire survey to evaluate the reliability and validity of the questionnaire.Results:The Chinese version of IIQ contained 24 items in four dimensions. Four common factors were extracted by exploratory factor analysis, and the cumulative variance contribution rate was 64.025%. Confirmatory factor analysis showed that each fitting index of the modified model was within the acceptable range. The Cronbach's α coefficients of rejection, acceptance, engulfing, and enrichment in Chinese IIQ were respectively 0.780, 0.800, 0.921, and 0.917. The split-half reliability coefficients were 0.824, 0.818, 0.943, and 0.929; the retest reliability coefficients were 0.695, 0.667, 0.725, and 0.572, respectively.Conclusions:The Chinese version of IIQ is reliable and valid and can be used to assess illness identity in patients with chronic diseases.
8.Clinical effects of combined tissue flap transplantation for repairing giant chest wall defects
Junyi YU ; Dajiang SONG ; Xu LIU ; Zhiyuan WANG ; Zan LI ; Yixin ZHANG ; Bo ZHOU ; Chunliu LYU ; Yuanyuan TANG ; Liang YI ; Zhenhua LUO ; Liyi YANG
Chinese Journal of Burns 2024;40(7):650-656
Objective:To investigate the clinical effects of combined tissue flap transplantation in repairing giant chest wall defects.Methods:This study was a retrospective observational study. From August 2013 to December 2020, 31 patients with chest wall tumor or radiation ulcer after radical resection of chest wall tumor and conformed to the inclusion criteria were admitted to the Department of Breast Oncoplastic Surgery of Hunan Cancer Hospital, including 12 males and 19 females, aged 25-71 years. After resection of tumor or ulcer and wound debridement, the area of secondary chest wall defect was 300-600 cm 2 with length of 16-35 cm and width of 16-32 cm. According to the actual situation of the patients and the preoperative design, the chest wall defects were repaired with the flexible combination of perforator flaps and myocutaneous flaps from different donor sites, and the area of the combined tissue flap was 260-540 cm 2 with length of 20-30 cm and width of 13-20 cm. Free posteromedial thigh perforator flap+free anterolateral thigh myocutaneous flap were used in 2 patients, free deep inferior epigastric artery perforator flap+free anterolateral thigh myocutaneous flap were used in 5 patients, free deep inferior epigastric artery perforator flap+pedicled rectus abdominis myocutaneous flap+free anterolateral thigh myocutaneous flap were used in 7 patients, free deep inferior epigastric artery perforator flap+pedicled rectus abdominis myocutaneous flap+pedicled latissimus dorsi myocutaneous flap were used in 2 patients, and bilateral free anterolateral thigh myocutaneous flaps were used in 15 patients. For the remaining small area of superficial tissue defect after being repaired by combined tissue flaps, skin graft was used to repair or delayed local flap transfering was performed after the tissue flaps survived and edema subsided. The appropriate blood vessels in the donor and recipient sites were selected for anastomosis to reconstruct the blood supply of tissue flaps. The wounds in the donor sites of tissue flaps that can be directly sutured were sutured directly; for those that cannot be sutured directly, the skin grafting or delayed suture was performed. The anastomosis of blood vessels in the recipient sites, operation length, and postoperative hospital stay were recorded. The survivals of tissue flaps and skin grafts, the shape and texture of reconstructed chest wall, the wound healing, scar formation, and function of donor sites of tissue flaps, and the scar formation of the donor sites of skin grafts were observed after operation. Tumor recurrence and death of recurrent patients were followed up after operation. Results:The blood vessels in the recipient sites were anastomosed as follows: proximal internal thoracic vessels for 24 times, distal internal thoracic vessels for 12 times, trunk of thoracodorsal vessels for 4 times, anterior serratus branches of thoracodorsal vessels for 8 times, and thoracoacromial vessels for 12 times. The operation length was 6.0 to 8.5 hours, and the postoperative hospital stay was 9 to 21 days. Necrosis at the edge of partial tissue flaps occurred in 4 patients after operation, which healed after dressing change, and the tissue flaps and skin grafts of the other patients survived completely. The shape and texture of the reconstructed chest wall were good. Four patients had poor wound healing in the donor sites of abdominal tissue flaps, which healed after dressing change and local drainage. Only linear scar was left in the donor sites of all tissue flaps, and there was no obvious dysfunction in the donor sites of tissue flaps. Mild hypertrophic scar was left in the donor sites of skin grafts. During follow-up of 9 to 36 months after operation, 6 patients had tumor recurrence, and the recurrence time was 5 to 20 months after operation. After comprehensive treatment for patients with tumor recurrence, 3 patients died.Conclusions:Transplantation of combined tissue flaps in repairing the giant chest wall defects can shorten the time of total operation and hospital stay, and avoid multiple operations. After operation, patients had good chest wall appearance, with reduced tumor recurrence in patients with chest wall tumor.
9.Prognostic value of serum levels of HMGB1,IL-34 and ANGPTL4 in patients with acute respiratory distress syndrome
Yongkang YANG ; Junyi CHEN ; Bo TANG
International Journal of Laboratory Medicine 2024;45(16):2028-2033
Objective To investigate the prognostic value of serum levels of high mobility group protein B1(HMGB1),interleukin-34(IL-34)and angiopoietin like protein 4(ANGPTL4)in patients with acute respira-tory distress syndrome(ARDS).Methods A total of 97 patients with acute respiratory distress syndrome from June 2021 to June 2023 were selected as the observation group,and 97 healthy patients from the hospital during the same period were selected as the control group.The levels of HMGB1,IL-34 and ANGPTL4 were compared between the two groups.The clinical data and serum levels of HMGB1,IL-34 and ANGPTL4 of pa-tients with different prognosis were compared and analyzed,and the influencing factors of prognosis were ana-lyzed.The predictive value of prognostic factors on prognosis was analyzed,and the predictive value of serum HMGB1,IL-34 and ANGPTL4 combined detection on prognosis was evaluated.Results The serum levels of HMGB1,IL-34 and ANGPTL4 in observation group were higher than those in control group,with statistical significance(P<0.05).Oxygenation index(PaO2/FiO2)in death group was lower than that in survival group,acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ)score,Murray lung injury score(MLIS),HMGB1,IL-34 and ANGPTL4 levels were higher than those in survival group,and the differences were statistically significant(P<0.05).PaO2/FiO2,APACHE Ⅱ score,MLIS,HMGB1,IL-34 and AN-GPTL4 levels were all prognostic factors of ARDS patients(P<0.05).The area under the curve(AUC)of PaO2/FiO2,APACHE Ⅱ score,MLIS and HMGB1,IL-34 and ANGPTL4 for predicting prognosis were 0.779,0.799,0.808,0.844,0.772 and 0.822,respectively.There was no significant difference in AUC among prognostic factors(P>0.05).The analysis of receiver operating characteristic curve showed that the AUC of se-rum HMGB1,IL-34 and ANGPTL4 combined to predict the prognosis of ARDS patients was 0.915(95%CI:0.841-0.962),which was significantly higher than that predicted by each indicator alone.Conclusion The combined detection of serum HMGB1,IL-34 and ANGPTL4 levels in ARDS patients has certain prognostic value.
10.Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner
Pei CAO ; Weigang ZHANG ; Junyi QIU ; Zuxiong TANG ; Xiaofeng XUE ; Tingting FENG
Cancer Research and Treatment 2024;56(1):259-271
Purpose:
Pancreatic cancer (PC) is a common malignant tumor of the digestive system, and its 5-year survival rate is only 4%. N6-methyladenosine (m6A) RNA methylation is the most common post-transcriptional modification and dynamically regulates cancer development, while its role in PC treatment remains unclear.
Materials and Methods:
We treated PC cells with gemcitabine and quantified the overall m6A level with m6A methylation quantification. Real-time quantitative reverse transcription polymerase chain reaction and Western blot analyses were used to detect expression changes of m6A regulators. We verified the m6A modification on the target genes through m6A-immunoprecipitation (IP), and further in vivo experiments and immunofluorescence (IF) assays were applied to verify regulation of gemcitabine on Wilms’ tumor 1–associated protein (WTAP) and MYC.
Results:
Gemcitabine inhibited the proliferation and migration of PC cells and reduced the overall level of m6A modification. Additionally, the expression of the “writer” WTAP was significantly downregulated after gemcitabine treatment. We knocked down WTAP in cells and found target gene MYC expression was significantly downregulated, m6A-IP also confirmed the m6A modification on MYC. Our experiments showed that m6A-MYC may be recognized by the “reader” IGF2BP1. In vivo experiments revealed gemcitabine inhibited the tumorigenic ability of PC cells. IF analysis also showed that gemcitabine inhibited the expression of WTAP and MYC, which displayed a significant trend of co-expression.
Conclusion
Our study confirmed that gemcitabine interferes with WTAP protein expression in PC, reduces m6A modification on MYC and RNA stability, thereby inhibiting the downstream pathway of MYC, and inhibits the progression of PC.


Result Analysis
Print
Save
E-mail